Preclinical development and in vivo efficacy of ceftiofur-PLGA microparticles

Vista sencilla de ítem
dc.contributor.authorVilos, Cristian
dc.contributor.authorVelasquez, Luis A.
dc.contributor.authorRodas, Paula I.
dc.contributor.authorZepeda, Katherine
dc.contributor.authorBong, Soung-Jae
dc.contributor.authorHerrera, Natalia
dc.contributor.authorCantin, Mario
dc.contributor.authorSimon, Felipe
dc.contributor.authorConstandil, Luis
dc.date.accessioned2023-06-19T13:30:55Z
dc.date.available2023-06-19T13:30:55Z
dc.date.issued2015-04
dc.descriptionIndexación: Scopuses
dc.description.abstractDrug delivery systems based on polymeric microparticles represent an interesting field of development for the treatment of several infectious diseases for humans and animals. In this work, we developed PLGA microparticles loaded with ceftiofur (PLGA-cef), a third-generation cephalosporin that is used exclusively used in animals. PLGA-cef was prepared by the double emulsion w/o/w method, and exhibited a diameter in the range of 1.5-2.2 μm, and a negative ζ potential in the range of -35 to -55 mV. The loading yield of PLGA-cef was ∼7% and encapsulation efficiency was approximately 40%. The pharmacokinetic study demonstrated a sustained release profile of ceftiofur for 20 days. PLGA-cef administrated in a single dose was more effective than ceftiofur non-encapsulated in rats challenged with S. Typhimurium. The in vivo toxicological evaluation showed that PLGA-cef did not affect the blood biochemical, hematological and hemostasis parameters. Overall, the PLGA-cef showed slow in vivo release profile, high antibacterial efficacy, and low toxicity. The results obtained supports the safe application of PLGA-cef as sustained release platform in the veterinary industry. © 2015 Vilos et al.es
dc.description.urihttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123335
dc.identifier.citationPLoS ONE Volume 10, Issue 427 April 2015 Article number e0123335es
dc.identifier.doi10.1371/journal.pone.0123335
dc.identifier.issn1932-6203
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/50800
dc.language.isoenes
dc.publisherPublic Library of Sciencees
dc.rights.licenseAtribución 4.0 Internacional (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectCeftiofures
dc.subjectPharmacokineticses
dc.subjectCephalosporinses
dc.titlePreclinical development and in vivo efficacy of ceftiofur-PLGA microparticleses
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
file.pdf
Tamaño:
3.71 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO EN INGLES
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
FM - Artículos de Revista